2/ Slowing the rate of aging has massive medical & financial benefits.
"Using a model of future health and spending in the USA, the effect of delayed aging resulting in 2.2 years add. life expectancy would yield US$7 trillion in savings over 50 years."
3/ The scientific case for aging has quickly gained credibility as pioneering companies make headway to solve aging.
The field of longevity biotech has attracted a growing wave of #investment.
Billions of #funding have already been put into early companies in this sector.
4/ As more #capital is flowing into the anti-aging #biotech sector, the major constraint now is the lack of #founders.
Many who want to get involved don’t know how to get started, or feel like they don’t have the background, network, or resources to be impactful...
5/ Enter: The On Deck Longevity Biotech (ODLB) Fellowship, a lifelong community of top founders, operators and investors passionate about building the future of longevity — together.
6/ Opportunities in the #longevity industry will be enormous in the coming decade. There is no better way to have the greatest #impact on age-related disease and #healthspan extension than by getting involved today.